New research in mice may explain why aspirin seems to lower the risk of people's cancers spreading out of control.

The company has asked the U.S. patent office to reconsider patents that could prevent it from selling an update to Keytruda.

Biotech Halozyme Therapeutics believes the new version of Merck's blockbuster cancer drug Keytruda infringes on its patents, ...

Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech ...

Striking study results last year indicated a new type of medicine may improve on Merck’s immunotherapy, spurring a wave of ...

Dr. Jie Yang, who carried out the researchm described the drug as a less expensive solution that is more accessible globally.

The groundbreaking study demonstrates drug candidate can safely and effectively target and eliminate senescent cells, also known as “zombie cells,” from the liver.

Cancer cells have an insatiable appetite for energy as they multiply more rapidly than normal cells. Greedy cancer cells ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...